Laboratory medicine · 2026
Stability of serum calprotectin as an emerging inflammatory biomarker: a five-day study at -20 °C and -80 °C using two analytical methods.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Čičak Helena, Šarčević Željka, Saračević Andrea, Dukić Lora, Galić Edvard, Alfirević Igor
Аннотация
INTRODUCTION: Serum calprotectin is an emerging inflammatory biomarker, but data on its stability remain limited. This study aimed to determine the 5-day stability of serum calprotectin stored at 2 temperatures: ‒20 °C and ‒80 °C.
METHODS: This study followed Checklist for Reporting Stability Studies recommendations using leftover serum samples. Analysis was undertaken using 2 analytical methods on an automated Siemens Atellica Solution analyzer. Twenty samples in ‒20 °C storage were analyzed using fCAL turbo reagent (BÜHLMANN), and another 10 samples in ‒20 °C storage were analyzed using GCAL reagent (Gentian Diagnostics). A further 10 patient samples stored at ‒80 °C were analyzed using fCAL turbo reagent. The maximum permissible difference was defined as total error, which was 56.43% for fCAL turbo reagent and 46.44% for GCAL reagent.
RESULTS: The instability equations were y = 7.6695 × time (days) and y = 0.8553 × time (days) for temperatures of ‒20 °C and ‒80 °C, respectively, when calprotectin was determined using fCAL turbo reagent and y = 12.7011 × time (days) at ‒20 °C using GCAL reagent.
DISCUSSION: Results from samples stored for a maximum of 5 days at ‒80 °C are more reliable than those stored at ‒20 °C, which may have an impact on clinical interpretation of the results.
METHODS: This study followed Checklist for Reporting Stability Studies recommendations using leftover serum samples. Analysis was undertaken using 2 analytical methods on an automated Siemens Atellica Solution analyzer. Twenty samples in ‒20 °C storage were analyzed using fCAL turbo reagent (BÜHLMANN), and another 10 samples in ‒20 °C storage were analyzed using GCAL reagent (Gentian Diagnostics). A further 10 patient samples stored at ‒80 °C were analyzed using fCAL turbo reagent. The maximum permissible difference was defined as total error, which was 56.43% for fCAL turbo reagent and 46.44% for GCAL reagent.
RESULTS: The instability equations were y = 7.6695 × time (days) and y = 0.8553 × time (days) for temperatures of ‒20 °C and ‒80 °C, respectively, when calprotectin was determined using fCAL turbo reagent and y = 12.7011 × time (days) at ‒20 °C using GCAL reagent.
DISCUSSION: Results from samples stored for a maximum of 5 days at ‒80 °C are more reliable than those stored at ‒20 °C, which may have an impact on clinical interpretation of the results.